Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Oncotarget | MTAP Loss in Metastatic Breast Cancer Patients: Genomic Landscape

News

March 14, 2023
PRESS RELEASE: On March 11, 2023, a new research paper was published in Oncotarget, entitled, “Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss.” continue reading »

Oncotarget | Selective Protection of Normal Cells From Chemotherapy, While Killing Drug-Resistant Cancer Cells

News

March 13, 2023
PRESS RELEASE: On March 11, 2023, Dr. Blagosklonny published a new review in Oncotarget, entitled, “Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells.” continue reading »

Oncotarget | Mitochondria Engage the Integrated Stress Response to Promote Tumor Growth

News

March 8, 2023
PRESS RELEASE: On February 25, 2023, researchers from the University of Colorado published a new editorial in Oncotarget, entitled, “Mitochondria engage the integrated stress response to promote tumor growth.” continue reading »

Oncotarget | HALP Score: Prognostic Ability in Cancers – A Literature Review

News

March 6, 2023
PRESS RELEASE: On February 25, 2023, Oncotarget published a new review, entitled, “What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types.” continue reading »

Oncotarget | Unveiling the Non-canonical Functions of EZH2 in Prostate Cancer

News

March 3, 2023
PRESS RELEASE: On February 11, 2023, researchers from Northwestern University published a new editorial in Oncotarget, entitled, “Unveiling the non-canonical functions of EZH2 in prostate cancer.” continue reading »